Mon.Jan 04, 2021

article thumbnail

How an all-or-nothing bet on 3 Bristol Myers drugs came undone

Bio Pharma Dive

With no decision from the FDA on approval of an experimental cancer cell therapy, an agreement by Bristol Myers to pay out more money as part of its Celgene acquisition fell apart.

Drugs 348
article thumbnail

10 things DTC marketers should focus on in 2021

World of DTC Marketing

KEY TAKEAWAY: Consumer behavior has changed due to the pandemic, and DTC marketers should be aware of how consumers will evaluate and choose prescription drugs. Many organizations have postponed market research due to the pandemic but knowledgeable DTC marketers should be aware of the progressive trends in healthcare. Here’s my list: 1ne: DTC should focus more on providing health information about advertised medications and less on “selling.” The overwhelming majority of consum

Marketing 271
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AbbVie, Biogen lead pharma in new year's drug price hikes

Bio Pharma Dive

Average list price increases across the drug industry, however, appear lower than last year, according to one analysis.

Drugs 269
article thumbnail

How to harness artificial intelligence to boost business and make our world more human

Scienmag

Welcome to the World of Hyperautomation Credit: World Scientific Two centuries ago, the Industrial Revolution began to automate “blue-collar” work, allowing higher profits and wider societal improvements like the reduction of famine and the increase in living standards. Today, Intelligent Automation has the ability to automate “white-collar” work, also called office work, in a shift […].

Engineer 108
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Surface plasmon resonance in biopharmaceutical industry: Real-time and label-free characterization

Bio Pharma Dive

Surface Plasmon Resonance (SPR) is a robust, but complex analytical tool that provides paramount value to the development and understanding biopharmaceutical products.

article thumbnail

How Big Data will accelerate the future of digital medicine in 2021

pharmaphorum

The pandemic has shed light on inefficiencies in healthcare systems, and provided an opportunity to adjust how we manage care in the future. Jennifer Haas, executive vice president of Noteworth, shares her 2021 predictions surrounding the future of telehealth and big data. . Healthcare providers are grappling with the task of scaling digital care delivery operations for ambulatory patients in response to the cost dynamics of effectively treating large populations with limited resources, especial

Big Data 111

More Trending

article thumbnail

CRUK scientists develop drug that targets KRAS pathways

Pharma Times

KRAS mutations are found in several hard-to-treat cancers

Scientist 160
article thumbnail

Chemo Drug Potentially More Potent than Remdesivir Against Coronavirus

BioSpace

Researchers with Shenzhen Institutes of Advanced Technology in China used a variety of computational techniques to simulate drug-virus interactions. They then screened 1,906 existing drugs to evaluate which ones might inhibit replication of SARS-CoV-2, the virus that causes COVID-19.

Drugs 101
article thumbnail

Using Define-XML for Dataset Design

pharmaphorum

In the past, sponsors submitting to FDA were required to submit a PDF describing their submission datasets. As we all know PDF is great for viewing on-screen or printing, but the information inside can’t be interpreted by a computer. Enter CDISC’s Define-XML model. Define-XML standardizes how to describe datasets in a machine-readable manner.

article thumbnail

Two Companies Ring in 2021 with Cash for Cancer and Rare Diseases

BioSpace

In the first week of the new year, two companies raised more than $150 million in separate Series A financing rounds to fund research programs aimed at developing treatments for cancer and rare diseases.

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Flucloxacillin vs Amoxicillin: 2 most POPULAR antibiotics

Druggist

Amoxicillin is the most commonly prescribed antibiotic in the UK, with over 6 mln prescriptions issued in the last 12 months. Flucloxacillin is less popular with around 3.6 mln prescriptions issued during the same time (OpenPrescribing.net, 2021). Both antibiotics’ distinct popularity comes mainly from different recommended use in the treatment of bacterial infections, even though both drugs belong to the same class of antibiotics: penicillins.

article thumbnail

Fujifilm Diosynth Opening Viral Vector Manufacturing Plant Near Boston

BioSpace

The new process development and manufacturing facility will focus on viral vectors and advanced therapies. It is the third location for Diosynth’s CDMO viral vector services.

article thumbnail

Strategy identified to enhance activity of CAR T-cells against breast cancer

BioPharma Reporter

A new study suggests that CAR T-cells, which are already used to treat certain blood cancers, may also be successful against solid tumors if combined with other immunotherapeutic approaches.

article thumbnail

Pfizer CMO Steps Down, Stanford Professor to Transition into Role

BioSpace

With the new year comes a changing of the guard at Pfizer. After two years of helming the company’s pharma operations, Chief Medical Officer Mace Rothenberg announced his departure from Pfizer on social media.

81
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Reawakened geyser does not foretell Yellowstone volcanic eruptions, study shows

Scienmag

Analysis of Steamboat Geyser also finds relationship between column height and reservoir depth Credit: UC Berkeley photo by Mara Reed When Yellowstone National Park’s Steamboat Geyser — which shoots water higher than any active geyser in the world — reawakened in 2018 after three and a half years of dormancy, some speculated that it was […].

98
article thumbnail

Moderna Raises Vaccine Manufacturing Goals and Other COVID-19 News

BioSpace

With COVID-19 still running rampant across the globe, Moderna announced it will rapidly expand its vaccine manufacturing operations in order to meet demand in the countries where the medication has received emergency authorization.

article thumbnail

UAB researcher develops technology to aid COVID-19 vaccine immunity monitoring

Scienmag

In advance of public vaccination, a quick and accurate COVID-19 antibody test will help determine the presence of neutralizing antibodies, the molecules that aid in protection against the virus. Credit: UAB BIRMINGHAM, Ala. – As the COVID-19 vaccine becomes available to the public, immunity monitoring will play an important role in determining whether the vaccine […].

article thumbnail

Roche set to file ophthalmology drug faricimab in DME

pharmaphorum

Roche looks set to mount a challenge to Bayer’s ophthalmology drug Eylea in 2021 after its faricimab antibody showed comparable results in diabetic macular oedema (DME) but with half the injections, in twin phase 3 studies. While Eylea (aflibercept) is taken in doses eight weeks apart, results from the YOSEMITE and RHINE studies showed faricimab produces a similar effect but with a 16-week dosing regimen.

Drugs 98
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Supercapacitors challenge batteries

Scienmag

Powerful graphene hybrid material for highly efficient supercapacitors Credit: Prof. Dr. J. Kolleboyina / IITJ A team working with Roland Fischer, Professor of Inorganic and Metal-Organic Chemistry at the Technical University Munich (TUM) has developed a highly efficient supercapacitor. The basis of the energy storage device is a novel, powerful and also sustainable graphene hybrid […].

article thumbnail

First person receives AstraZeneca’s COVID-19 vaccine in the UK

BioPharma Reporter

The first dose of AstraZenecaâs COVID-19 vaccine has been administered in the UK this morning, after it was authorized for emergency supply last week.

article thumbnail

Sweetened beverage sales bounced back quickly after Cook County tax repealed

Scienmag

Study published in JAMA Network Open Credit: UIC Following the repeal of the short-lived Cook County, Illinois Sweetened Beverage Tax, sales of sweetened beverages went right back to where they were before the tax went into place, according to a new study led by researchers at the University of Illinois Chicago. The study is published […].

Sales 97
article thumbnail

AbbVie Says Goodbye to Sosei’s Neurological-Focused Muscarinic Agonist Programs

BioSpace

Sosei Group Corporation has announced it is regaining the worldwide rights to its muscarinic agonist programs after AbbVie said it is backing away from the program.

98
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Risk of extinction cascades from freshwater mussels to a bitterling fish

Scienmag

Decline of unionid mussels heightens hybridisation of native and introduced bitterling fish Credit: Hiroki Hata (Ehime University) Bitterling fishes (Subfamily: Acheilognathinae) spawn in the gills of living freshwater mussels obligately depending on the mussels for reproduction. On the Matsuyama Plain, Japan, populations of unionid mussels–Pronodularia japanensis, Nodularia douglasiae, and Sinanodonta lauta–have decreased rapidly over the […].

article thumbnail

Cell Therapy Speed and Efficiency Driven by Draper’s New Way of Thinking

BioSpace

Draper, a not-for-profit research and development organization, is speeding the process with new tools designed specifically to produce cell therapies at scale.

article thumbnail

Alpha-ray missile therapy: tumor cells attacked from intracellular region

Scienmag

Researchers at Osaka University have developed a technique of attacking cancer cells with lethal alpha rays from within by using a nutrient transporter to deliver radionuclides into malignant tumors Credit: Osaka University Osaka, Japan – A cancer-specific L-type amino acid transporter 1 (LAT1) is highly expressed in cancer tissues. Inhibiting the function of LAT1 has […].

article thumbnail

2021 Biopharma Update on the Novel Coronavirus: January 5

BioSpace

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 5, 2021.

98
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Eurasian eagle owl diet reveals new records of threatened giant bush-crickets

Scienmag

Credit: Dragan Chobanov Bird diets provide a real treasure for research into the distribution and conservation of their prey, such as overlooked and rare bush-cricket species, point out scientists after studying the diet of the Eurasian Eagle Owl (Bubo bubo) in southeastern Bulgaria. In their paper, published in the open-access, peer-reviewed journal Travaux du Muséum […].

article thumbnail

AstraZeneca/Oxford University's COVID-19 vaccine set for UK rollout

Pharma Times

Shot was approved by MHRA on 30 December

article thumbnail

Interactive game created by a Lithuanian team won World Summit Awards

Scienmag

An interactive educational game ‘Flight Across the Atlantic’ featuring the legendary flight of Lithuanian pilots was announced as one of the winners in the global digital innovation competition World Summit Awards (WSA) Credit: KTU An interactive educational game “Flight Across the Atlantic” featuring the legendary flight of Lithuanian pilots Steponas Darius and Stasys Girenas was […].

article thumbnail

Janssen files EGFR-targeting antibody amivantamab with EMA

Pharma Times

Submission based on results from phase I CHRYSALIS study

Antibody 124
article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.